Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: pharmaceutical and medical devices. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. Geographically, just over half of total revenue is generated in the United States.
The current price of Johnson & Johnson in the market is 10 471,05 ₴, with a 24-hour trading volume of 63,96M ₴. The asset's market cap is 25,22T ₴, after moving 0.15% in the last day.
Tokenized Johnson & Johnson is trading at 10 519,25 ₴, with a tokenized market cap of 42,78M ₴ and a 24-hour trading volume of 37,57M ₴. The tokenized asset has moved 1.30% in the past 24 hours.